Preferred Label : Twice;

NCIt synonyms : Two Times;

NCIt definition : Two times.;

Alternative definition : CDISC: Two times. (NCI);

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3519072/fr/sensura-mio
2024
France
health technology assessment
Stoma
Device System
coins
stoma site, nos
Stomatocyte Count
numismatics
MLXIPL wt Allele
equipment and supplies, hospital
Protector Device
Drug Delivery System
Supper
convex shape
Drug Delivery System Category
Twice
support, nos
Mount Device

---
https://dumas.ccsd.cnrs.fr/dumas-04583664
2024
France
dissertations, academic
Instruction
teaching methods
Technique
health
Twice
teaching
echocardiography
Echocardiography
Nonclinical Randomization
Comparison
Low Grade Vaginal Intraepithelial Neoplasia
prospective studies
Prospective Cohort Study
echocardiography, nos
Prospective Study
sampling studies

---
https://www.cochrane.org/fr/CD014763/COLOCA_comparaison-de-deux-methodes-de-fermeture-de-la-plaie-dans-linversion-de-stomie-fermeture-par-cordon
2024
United Kingdom
review of literature
french abstract
XML Bound
Cutaneous
Binding
skin, nos
inversion
Enclosure Device
Fastener Device
Twice
Reversal
Stomatocyte Count
Comparison
Cord Device
Injury
Present
Inversion
EDQM-HC Closure Terminology
Wound
Pound
Technique
scrotum
wound, nos
protestantism
stoma site, nos
HNRNPM wt Allele
Cord
Stoma

---
https://www.santepubliquefrance.fr/presse/2024/bronchiolite-deux-etudes-francaises-demontrent-l-efficacite-du-beyfortus-R-dans-la-prevention-des-cas-graves-et-la-reduction-des-hospitalisations
2024
France
scientific and technical information
BCAR1 wt Allele
hospitalization
Bronchiolitis
No Cases Transmission Pattern
Reduction
Packaging Case
infant
CTNND1 wt Allele
Reduced
Catenin Delta-1
Coronavirus Anxiety Scale
efficiency
Twice
Case
Efficacy Study
hospital admission, nos
bronchiolitis, nos
Case Dosing Unit
bronchiolitis
Breast Cancer Anti-Estrogen Resistance Protein 1
Prevention
True Case Status
Hospitalization
Prevention Study
Preventive Intervention
snacks

---
https://www.has-sante.fr/jcms/p_3519069/fr/sensura-mio
2024
France
health technology assessment
Drug Delivery System Category
Supper
stoma site, nos
Drug Delivery System
Malignant Germ Cell International Collaborative Risk Classification, Standard
MLXIPL wt Allele
Standard Drug Stability Study
Stomatocyte Count
Stoma
reference standards
Standard
numismatics
support, nos
Device System
Twice
telephone switchboard operator
coins
Mount Device
Protector Device
Standard
equipment and supplies, hospital
Standard Environmental Condition

---
https://orbi.uliege.be/handle/2268/320601
2024
Belgium
journal article
death
neoplasms
Twice
Cancer Prevention
Non-Cancer Related Death
neoplasm, malignant
cancer

---
https://www.has-sante.fr/jcms/p_3519075/fr/sensura-mio
2024
France
health technology assessment
digestant, nos
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
IDH Family Mutation Analysis Was Not Performed
Norway
IV Anesthesia was not Administered
Additional Surgery for New Metastatic Tumor Event Was Not Performed
No History of Kawasaki Disease
No Known History of Illicit Drug Use
First Degree Family History of Primary Brain Tumor Negative
Minor Criteria for Rheumatic Heart Disease Not Present
Bag
Nitric Oxide Measurement
No History of Neonatal Complication
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Device System
Pouch Dosing Unit
NRAS Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
ERBB2 Mutation Analysis Was Not Performed
Documentation Absent
First Degree Family History Thyroid Cancer Negative
RET Rearrangement Analysis Was Not Performed
Regional Anesthesia was not Administered
No History of Non-Cardiac Surgery
KIT Mutation Analysis Was Not Performed
Drug Delivery System
IDH Family Wildtype
Another Form of Birth Control was not Used
digestion
No History of Gestational Complication
Pouch
Stoma
Not Lost to Follow-Up
1p/19q Deletion Analysis Was Not Performed
Preoperative IV Opiates were not Administered
EGFR Amplification Analysis Was Not Performed
numismatics
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
MET Mutation Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Lymph Node Dissection Was Not Performed
MLXIPL wt Allele
ATRX Mutation Analysis Was Not Performed
Chief Complaint was Not Witnessed
Intercurrent Illness is Absent at Onset of Chief Complaint
Preoperative IV Sedation was Not Administered
No Known History of Alcohol Use
digestants
Cancer History Absent
Hypertension Absent
PTEN Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
Negation
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Congenital Heart Disease
EGFR Gene Amplification Negative
Twice
Any Metastatic Diagnosis Absent
Family History of Stomach Cancer Absent
Additional Surgery for New Tumor Event Absent
ATRX Gene Mutation Negative
Local Anesthesia Agents were not Administered
Additional Immunohistochemistry Was Not Performed
enterostomy
First Degree Family History Cancer Negative
Intervention Not Given for Kawasaki Disease
Neither Case or Control Status
Nitric Oxide
Adjuvant Post-operative Chemotherapy Was Not Administered
digestive tract function, nos
PTEN Gene Mutation Negative
Has No Sibling
Adjuvant Post-operative Immunological Therapy Was Not Administered
History of Medical Treatment Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Digestion
Preoperative IV Antiemetics were not Administered
Chemotherapy Not Received
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Unemployed
Preoperative IV Antacids were not Administered
Other Preoperative IV Medications were not Administered
Adjuvant I-131 Therapy Negative
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
stoma site, nos
ALK Rearrangement Analysis Was Not Performed
Stomatocyte Count
Medication Not Taken
No History of Myopathy
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
PDGFRA Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Drug Delivery System Category
Pouch Dosage Form Category
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chief Complaint Not Caused by Trauma
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
TP53 Mutation Analysis Was Not Performed
Patient was not Postmenopausal with no Prior Oophorectomy
Chemical/Occupational Exposure Absent
coins
SDH Complex Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
Therapeutic Ionizing Radiation to Head History Absent
BRAF Mutation Analysis Was Not Performed
Radiation History Negative
No History of Rheumatic Fever
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
equipment and supplies, hospital
Physician Diagnosed Diabetes Absent
EGFR Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
History of Colorectal Cancer Negative
Tumor Progression Absent After Initial Treatment
Use of Smokeless Tobacco at Time of Diagnosis Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Patient was Not Previously Evaluated for Current Chief Complaint
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Radiation Therapy Not Received
New Disease is not Multifocal
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Additional Molecular Studies Were Not Performed
No Response to Intervention for Kawasaki Disease
Paraneoplastic Syndrome is Not Present
Caffeine Not Routinely Consumed
10q23/PTEN Locus Deletion Analysis Was Not Performed
NF1 Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Fluorescence In Situ Hybridization Was Not Performed

---
https://www.has-sante.fr/jcms/p_3519081/fr/sensura-mio
2024
France
health technology assessment
numismatics
Drug Delivery System
coins
enterostomy
Device System
Pouch
Stomatocyte Count
Pouch Dosage Form Category
Drug Delivery System Category
digestive system
digestive tract function, nos
Pouch Dosing Unit
Twice
Bag
digestant, nos
equipment and supplies, hospital
MLXIPL wt Allele
Digestion
Stoma
ostomy collection bag

---
https://www.has-sante.fr/jcms/p_3519087/fr/sensura-mio
2024
France
health technology assessment
urinary tract, nos
Pouch
Twice
equipment and supplies, hospital
numismatics
Urinary System
MLXIPL wt Allele
Stomatocyte Count
Bag
urinary tract
urinary reservoirs, continent
ostomy collection bag
Pouch Dosing Unit
Stoma
Murine Urinary System
coins
Pouch Dosage Form Category

---
https://www.inrs.fr/media.html?refINRS=TD%20316
2024
France
journal article
forecasting
paris
occupational musculoskeletal disorders
Ergonomics
Scientific Equipment
Computer Job
Twice
occupation, nos
Work
Angola
Phase II/III Trial
Worksite
future
November
What Month is it
Musculoskeletal Disorder
work
Occupation
Twenty Three
equipment and supplies
Twenty Four
equipment
attentiveness

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-christel-protiere
2023
France
audiovisual aids
Additional Molecular Studies Were Not Performed
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Tumor Progression Absent After Initial Treatment
Sex
Adjuvant I-131 Therapy Negative
Chemical/Occupational Exposure Absent
KRAS Mutation Analysis Was Not Performed
MET Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
NRAS Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
KIT Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Norway
IDH Family Mutation Analysis Was Not Performed
Another Form of Birth Control was not Used
NON Mouse
No Known History of Alcohol Use
Nitric Oxide Measurement
NF1 Mutation Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Opiates were not Administered
Diversity
ALK Rearrangement Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Sex Behavior
EGFR Gene Amplification Negative
MGMT Promoter Methylation Testing Was Not Performed
TP53 Mutation Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
CDISC SDTM Sex of Individual Terminology
Preoperative IV Antiemetics were not Administered
Fluorescence In Situ Hybridization Was Not Performed
Chief Complaint Not Caused by Trauma
Lymph Node Dissection Was Not Performed
Any Metastatic Diagnosis Absent
New Disease is not Multifocal
drug users
Preoperative IV Sedation was Not Administered
attentiveness
Therapeutic Ionizing Radiation to Head History Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
ATRX Gene Mutation Negative
No History of Congenital Heart Disease
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Rheumatic Fever
Application Context
Analysis
Other Preoperative IV Medications were not Administered
analysis, cohort
Documentation Absent
History of Colorectal Cancer Negative
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Twice
Minor Criteria for Rheumatic Heart Disease Not Present
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Family History of Stomach Cancer Absent
Chemotherapy Not Received
Physician Diagnosed Diabetes Absent
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
First Degree Family History of Primary Brain Tumor Negative
First Degree Family History Cancer Negative
Hypertension Absent
Outcome Assessment, Health Care
Adjuvant Post-operative Immunological Therapy Was Not Administered
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
EGFR Amplification Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Additional Immunohistochemistry Was Not Performed
Analyzed
No Response to Intervention for Kawasaki Disease
Routine Cytogenetics Were not Completed
Paraneoplastic Syndrome is Not Present
cohort studies
Not Lost to Follow-Up
No History of Gestational Complication
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Cancer History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Nitric Oxide
Caffeine Not Routinely Consumed
ROS1 Rearrangement Analysis Was Not Performed
No History of Non-Cardiac Surgery
10q23/PTEN Locus Deletion Analysis Was Not Performed
Unemployed
History of Medical Treatment Absent
Radiation Therapy Not Received
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
ATRX Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Has No Sibling
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Comparison
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
drugged state
1p/19q Deletion Analysis Was Not Performed
Cohort Study
Neither Case or Control Status
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
No History of Kawasaki Disease
Radiation History Negative
Tumor Reoccurrence Absent After Initial Treatment
ERBB2 Mutation Analysis Was Not Performed
resulting in
Evidence of Disease Absent after Completion of Therapy
No Known History of Illicit Drug Use
Medication Not Taken
Preoperative IV Antacids were not Administered
Chief Complaint was Not Witnessed
Negation
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
IV Anesthesia was not Administered
EGFR Mutation Analysis Was Not Performed
No History of Myopathy
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Neonatal Complication
PTEN Gene Mutation Negative

---
http://beh.santepubliquefrance.fr/beh/2023/18/2023_18_1.html
2023
false
false
false
France
journal article
Feel Anxious
Inquiry
Survey
CHFR Gene
Data Set
prevalence
anxiety
Suicidal Ideation
Depression Visual Analogue Scale
Data
Investigation
Depression, CTCAE
Anxiety, CTCAE 3.0
Hexagon
dataset
anxious mood
france
Twice
No Information Available
depression
Worry
Anxiety
detective
perinatal state, nos
Anxiety Disorder
anxiety
Prevalent
depressive disorder
Depression Subordinate Domain
french
Depression
depression, nos
suicidal ideation

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.